CLL/Lymphomas: Key Trials From ASH 2019

December 7-10, 2019; Orlando, Florida
Download this summary slideset with highlights of key data in chronic lymphocytic leukemia and lymphomas from ASH 2019.
Format: Microsoft PowerPoint (.ppt)
File Size: 1.69 MB
Released: December 23, 2019

Acknowledgements

Supported by educational grants from
AbbVie
AstraZeneca
Gilead Sciences
Jazz Pharmaceuticals, Inc.

Related Content

Preview expert ITP abstract selections from ASH 2020 as part of conference coverage from Clinical Care Options (CCO)

David J. Kuter, MD, DPhil Released: November 24, 2020

CCO commentary from Shaji Kumar, MD, on key issues in the management of multiple myeloma

Shaji Kumar, MD Released: November 23, 2020

Expert commentary from Clinical Care Options (CCO) on challenges in diagnosing and treating patients with myelodysplastic syndromes (MDS)

Rami S. Komrokji, MD Released: November 20, 2020

Enter the characteristics of your patient with CLL into this online tool from Clinical Care Options (CCO) to see treatment recommendations from 5 experts

Jeff P. Sharman, MD
Program Director
Released: November 20, 2020

Leaving the CCO site

You are now leaving the CCO site. The new destination site may have different terms of use and privacy policy.

Continue